Ryan S Creech

  • Citations Per Year
Learn More
BACKGROUND There are no randomized, placebo-controlled data for quetiapine in outpatients with bipolar spectrum disorder (ambulatory BSD) and moderate-to-severe hypomanic or mild manic symptoms (hypomania/mild mania). METHODS An 8-week, randomized, double-blind, placebo-controlled trial of quetiapine in ambulatory BSD with hypomanic/mild manic symptoms,(More)
OBJECTIVE To determine whether divalproex extended release (ER) would be effective in outpatients with DSM-IV-TR-diagnosed ambulatory bipolar spectrum disorder (BSD) and moderate-to-severe hypomanic or mild manic symptoms (hypomania/mild mania). METHOD An 8-week, randomized, double-blind, placebo-controlled trial of divalproex ER oral loading (begun at 15(More)
  • 1